• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>FASEB BioAdvances >Advancing science and education through a novel collaboration platform between the University of Michigan and Peking University Health Science Center
【2h】

Advancing science and education through a novel collaboration platform between the University of Michigan and Peking University Health Science Center

机译：通过密歇根大学和北京大学卫生科学中心的新颖协作平台推进科学和教育

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Research in China has been advancing over the past decade with increasing investments from government and private entities. Collaboration with Chinese investigators and those in the United States has also increased as reflected in the growth of scientific papers with Chinese authors. Collaborations are more commonly based on faculty‐to‐faculty relationships which can be challenged by institutional or governmental policies. This paper reports on an institution‐to‐ institution collaboration, the Joint Institute for Translational and Clinical Research initiated in 2010 between the University of Michigan Medical School and Peking University Health Science Center, to enable and support collaborative faculty‐initiated research. Concomitant education and training programs have also been co‐developed. Beginning in 2011, 190 proposals from faculty‐to‐faculty partnerships have been submitted from which 59 have been selected for funding. These projects have involved over 138,000 patient subjects and resulted in 86 peer‐reviewed publications to date. Pilot data has been leveraged to secure $27.3 million dollars of extramural funding outside of China. Faculty and trainee exchanges take place regularly including an annual symposium with mechanisms to link faculty who are seeking partnerships by utilizing each other's complementary strengths and resources. As the collaboration enters its second decade, both institutions believe that the model offers a unique platform to promote faculty‐initiated collaborative research. Next steps include funding studies in prioritized scientific themes, and promoting access to high‐quality cohorts to attract industry partners and to develop sustainable financial models.
机译：中国的研究在过去十年中一直在推进政府和私人实体的投资。与中国作者的科学论文增长相比，与中国调查人员和美国的合作也有所增加。合作更常见的是基于能够受到机构或政府政策挑战的教师的关系。本文报告了一项机构 - 制度合作，2010年密歇根州医学院大学和北京大学卫生科学中心开展的临床研究所，启用和支持协作教师启动研究。伴随着教育和培训计划也得到了共同发展。从2011年开始，已经提交了来自教职员工伙伴关系的190个提案，其中已被选中59份资助。这些项目涉及超过138,000名患者受试者，并导致迄今为止审查了86个同行评审出版物。已经利用试点数据来保护中国以外的2730万美元的营业资金。教师和实习生经常举行，包括一名年度研讨会，通过利用彼此的互补优势和资源来联系正在寻求合作伙伴关系的机制。由于合作进入其第二十年，这两个机构都认为该模型提供了一个独特的平台，以促进教师启动的协作研究。下一步包括优先考虑科学主题的资助研究，并促进获得高质量群体以吸引行业合作伙伴并制定可持续的金融模式。

著录项

  • 期刊名称 FASEB BioAdvances
  • 作者

    Joseph C. Kolars; Qimin Zhan;

  • 作者单位
  • 年(卷),期 2021(3),6
  • 年度 2021
  • 页码 428–438
  • 总页数 11
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

    机译：生物医学研究;中国;国际教育交流;支持研究;翻译医学研究;

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号